Literature DB >> 17728000

Lectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution.

YaShu Yin1, DaWei Chen, MingXi Qiao, XiuYan Wei, HaiYang Hu.   

Abstract

The conjugation of lectins onto PLGA nanoparticles has been demonstrated to effectively improve the intestinal absorption of thymopentin. In this study, thymopentin-loaded nanoparticles made from fluorescein isothiocyanate labeled PLGA were modified with wheat germ agglutinin (WGA). The specific bioadhesion of nanoparticles on rat intestinal mucosa was studied ex vivo. An important increase of interaction between WGA-conjugated nanoparticles and the intestinal segments was observed compared with that of the unconjugated one (p<0.05). Fluorescence photomicrographs confirmed the bioadhesion of WGA-conjugated nanoparticles on intestinal villous epithelium as well as Peyer's patches. Biodistribution of nanoparticles was evaluated using tissues obtained from rats, to which nanoparticles were orally administered. The highest amount of WGA-conjugated nanoparticles was detected in small intestine, suggesting an increase of intestinal bioadhesion and endocytosis. The systemic uptake was as high as 6.48-13.4% of dose at 1 day and 7.32-15.26% at 7 days, which representing an increase of almost 1.4-3.1 fold across the intestine compared to <4.9% of the unconjugated one. The enhanced uptake was related to the increasing of WGA density on nanoparticles. These results further revealed the promising potential of lectin-conjugated nanoparticles on the improvement of intestinal bioadhesion and absorption for oral drug delivery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17728000     DOI: 10.1016/j.jconrel.2007.06.024

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  17 in total

1.  Thymopentin-loaded phospholipid-based phase separation gel with long-lasting immunomodulatory effects: in vitro and in vivo studies.

Authors:  Ting Zhang; Xian-Yan Qin; Xi Cao; Wen-Hao Li; Tao Gong; Zhi-Rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-07-12       Impact factor: 6.150

Review 2.  Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.

Authors:  Laura M Ensign; Richard Cone; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2011-12-24       Impact factor: 15.470

3.  In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery.

Authors:  Yen Cu; Carmen J Booth; W Mark Saltzman
Journal:  J Control Release       Date:  2011-07-08       Impact factor: 9.776

4.  Effect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in rats.

Authors:  Dengning Xia; Fude Cui; Hongze Piao; Dongmei Cun; Hongyu Piao; Yanbo Jiang; Mei Ouyang; Peng Quan
Journal:  Pharm Res       Date:  2010-06-29       Impact factor: 4.200

5.  Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.

Authors:  Sutapa Barua; Samir Mitragotri
Journal:  Nano Today       Date:  2014-04-01       Impact factor: 20.722

6.  Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days.

Authors:  Sara M Navarro; Caleb Darensbourg; Linda Cross; Rhett Stout; Diana Coulon; Carlos E Astete; Timothy Morgan; Cristina M Sabliov
Journal:  Ther Deliv       Date:  2014-11

Review 7.  Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.

Authors:  Yeonhee Yun; Yong Woo Cho; Kinam Park
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

8.  Nanoparticles that do not compete with endogenous ligands - Molecular characterization in vitro, acute safety in canine, and interspecies pharmacokinetics modeling to humans.

Authors:  Dianxiong Zou; Meenakshi Arora; Raghu Ganugula; Mokshada Kumar; Erin M Scott; Dhaval Shah; M N V Ravi Kumar
Journal:  J Control Release       Date:  2021-02-16       Impact factor: 9.776

9.  Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part II: In vitro and in vivo Kinetics Study.

Authors:  Aya Ahmed Sebak; Iman Emam Omar Gomaa; Aliaa Nabil ElMeshad; Mahmoud Hussien Farag; Ulrike Breitinger; Hans-Georg Breitinger; Mahmoud Hashem AbdelKader
Journal:  Int J Nanomedicine       Date:  2020-11-30

10.  Ligand-modified gene carriers increased uptake in target cells but reduced DNA release and transfection efficiency.

Authors:  Yen Cu; Cathy LeMoëllic; Michael J Caplan; W Mark Saltzman
Journal:  Nanomedicine       Date:  2009-10-02       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.